The predictive and prognostic effects of PD-L1 expression on TKI treatment and survival of EGFR-mutant NSCLC: A meta-analysis

Whether programmed death-ligand 1 (PD-L1) expression could predict the outcome of tyrosine kinase inhibitor (TKI) treatment and prognosis of epidermal growth factor receptor (EGFR)-mutant nonsmall cell lung cancer (NSCLC) is remaining controversial. Potential studies were search from PubMed, Embase,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Bo, Wang, Yongfang, Wu, Jingni, Wang, Kai, Wang, Pingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389972/
https://www.ncbi.nlm.nih.gov/pubmed/34449486
http://dx.doi.org/10.1097/MD.0000000000027038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389972/
https://www.ncbi.nlm.nih.gov/pubmed/34449486
http://dx.doi.org/10.1097/MD.0000000000027038

Ejemplares similares